NovaVision, which provides medical devices to restore the vision of patients with neurological visual impairments, has appointed Rudy Mazzocchi as its new CEO.
Subscribe to our email newsletter
Most recently, Mr Mazzocchi served as managing director of Accuitive Medical Ventures, an Atlanta-based venture capital fund that specializes in early-stage medical technology investments. Prior to that Mr Mazzocchi served as chairman and interim CEO of Triton BioSystems.
Navroze Mehta, founder of NovaVision will be vice chairman of the board of directors, said: “I am excited about the role Rudy will play in leading the company into the future. His outstanding experiences will allow NovaVision to continue to grow and greatly expand the accessibility to patients with impaired vision.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.